These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22074352)

  • 1. Toward in vivo imaging of heart disease using a radiolabeled single-chain Fv fragment targeting tenascin-C.
    Kobayashi N; Odaka K; Uehara T; Imanaka-Yoshida K; Kato Y; Oyama H; Tadokoro H; Akizawa H; Tanada S; Hiroe M; Fukumura T; Komuro I; Arano Y; Yoshida T; Irie T
    Anal Chem; 2011 Dec; 83(23):9123-30. PubMed ID: 22074352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive detection of cardiac repair after acute myocardial infarction in rats by 111 In Fab fragment of monoclonal antibody specific for tenascin-C.
    Odaka K; Uehara T; Arano Y; Adachi S; Tadokoro H; Yoshida K; Hasegawa H; Imanaka-Yoshida K; Yoshida T; Hiroe M; Irie T; Tanada S; Komuro I
    Int Heart J; 2008 Jul; 49(4):481-92. PubMed ID: 18753731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful Inflammation Imaging of Non-Human Primate Hearts Using an Antibody Specific for Tenascin-C.
    Ageyama N; Kurosawa H; Fujimoto O; Uehara T; Hiroe M; Arano Y; Yoshida T; Yasutomi Y; Imanaka-Yoshida K
    Int Heart J; 2019 Jan; 60(1):151-158. PubMed ID: 30464121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid infarct imaging with a technetium-99m-labeled antimyosin recombinant single-chain Fv: evaluation in a canine model of acute myocardial infarction.
    Nedelman MA; Shealy DJ; Boulin R; Brunt E; Seasholtz JI; Allen IE; McCartney JE; Warren FD; Oppermann H; Pang RH
    J Nucl Med; 1993 Feb; 34(2):234-41. PubMed ID: 8429342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of experimental autoimmune myocarditis in rats by 111In monoclonal antibody specific for tenascin-C.
    Sato M; Toyozaki T; Odaka K; Uehara T; Arano Y; Hasegawa H; Yoshida K; Imanaka-Yoshida K; Yoshida T; Hiroe M; Tadokoro H; Irie T; Tanada S; Komuro I
    Circulation; 2002 Sep; 106(11):1397-402. PubMed ID: 12221059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
    Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
    Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-chain variable fragment (scFv) antibodies optimized for environmental analysis of uranium.
    Zhu X; Kriegel AM; Boustany CA; Blake DA
    Anal Chem; 2011 May; 83(10):3717-24. PubMed ID: 21473651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting prostate cancer cells in vivo using a rapidly internalizing novel human single-chain antibody fragment.
    He J; Wang Y; Feng J; Zhu X; Lan X; Iyer AK; Zhang N; Seo Y; VanBrocklin HF; Liu B
    J Nucl Med; 2010 Mar; 51(3):427-32. PubMed ID: 20150269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and purification of a novel therapeutic single-chain variable fragment antibody against BNP from inclusion bodies of Escherichia coli.
    Bu D; Zhou Y; Tang J; Jing F; Zhang W
    Protein Expr Purif; 2013 Dec; 92(2):203-7. PubMed ID: 24128692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor Penetrating Peptide-Functionalized Tenascin-C Antibody for Glioblastoma Targeting.
    Lingasamy P; Laarmann AH; Teesalu T
    Curr Cancer Drug Targets; 2021; 21(1):70-79. PubMed ID: 33001014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved tumor targeting with chemically cross-linked recombinant antibody fragments.
    King DJ; Turner A; Farnsworth AP; Adair JR; Owens RJ; Pedley RB; Baldock D; Proudfoot KA; Lawson AD; Beeley NR
    Cancer Res; 1994 Dec; 54(23):6176-85. PubMed ID: 7954464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic expression of tenascin-C after myocardial ischemia and reperfusion: assessment by 125I-anti-tenascin-C antibody imaging.
    Taki J; Inaki A; Wakabayashi H; Imanaka-Yoshida K; Ogawa K; Hiroe M; Shiba K; Yoshida T; Kinuya S
    J Nucl Med; 2010 Jul; 51(7):1116-22. PubMed ID: 20554738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of human single-chain variable fragment antibodies against anaplastic thyroid carcinoma, and single photon emission‑computed tomography/computed tomography imaging in tumor-bearing nude mice.
    Liu Q; Pang H; Liu Q; Zhou J; Liu Y
    Oncol Rep; 2017 May; 37(5):2980-2986. PubMed ID: 28393196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel variable antibody fragment dimerized by leucine zippers with enhanced neutralizing potency against rabies virus G protein compared to its corresponding single-chain variable antibody fragment.
    Li Z; Cheng Y; Xi H; Gu T; Yuan R; Chen X; Jiang C; Kong W; Wu Y
    Mol Immunol; 2015 Dec; 68(2 Pt A):168-75. PubMed ID: 26325475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a 99mTc-antimyosin kit for myocardial infarct imaging.
    Rousseau J; Sikorska HM; Gervais A; Bisson G; Margaron P; Lamoureux G; Mirza SA; van Lier JE
    J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):43-53. PubMed ID: 7632767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of an scFv library by enzymatic assembly of V(L) and V(H) genes.
    Kato M; Hanyu Y
    J Immunol Methods; 2013 Oct; 396(1-2):15-22. PubMed ID: 23916870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of divalent anti-keratin 8 single-chain antibodies (sc(Fv)(2)), expression in Pichia pastoris and their reactivity with multicellular tumor spheroids.
    Jafari R; Holm P; Piercecchi M; Sundström BE
    J Immunol Methods; 2011 Feb; 364(1-2):65-76. PubMed ID: 21093447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and biodistribution of engineered single-chain antibody constructs of MAb CC49 in colon carcinoma xenografts.
    Pavlinkova G; Beresford GW; Booth BJ; Batra SK; Colcher D
    J Nucl Med; 1999 Sep; 40(9):1536-46. PubMed ID: 10492377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization and modification of anti-rhTNF-α single chain variable fragment antibody: effective in vitro affinity maturation and functional expression of chimeric Fab.
    Miao X; Li A; Chen W; Qi H; Qiu Z; Zhang Y; Zhang J; Wang M
    Biomed Pharmacother; 2013 Jun; 67(5):437-44. PubMed ID: 23582792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Codon modification for the DNA sequence of a single-chain Fv antibody against clenbuterol and expression in Pichia pastoris.
    Dong JX; Xie X; Hu DW; Chen SC; He YS; Beier RC; Shen YD; Sun YM; Xu ZL; Wang H; Yang JY
    Appl Microbiol Biotechnol; 2014 Apr; 98(8):3679-89. PubMed ID: 24190495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.